Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 25211-25220 Newer>

The Motley Fool August 6, 2007 Anders Bylund	Silicon Image On Fire Sale Silicon Image beat its internal targets and guided to double-digit revenue growth and continued margin improvement in the next quarter. And for this, the stock price took a 31% fall in just two days.
The Motley Fool August 6, 2007 Andrew R. Vaino	NPS Pharmaceuticals: What's for Dinner? The small biotech pins its hopes on a drug that helps patients digest their food. Because the company's market cap is just $180 million, shares could jump significantly on a positive clinical result.
The Motley Fool August 6, 2007 Brian Orelli	Hopeful Investors Stoke Pharmion's Price Clinical trials to get a drug approved for new uses usually don't have the gusto that trials for the original New Drug Application have, but Pharmion results released last week have blown the stock price through the roof.
The Motley Fool August 6, 2007 Timothy M. Otte	Are Haverty Sales Bottoming Out? The furniture retailer reports a second-quarter loss, and the numbers reflect the general weakness of everything related to the home. Investors, take note.
The Motley Fool August 6, 2007 David Lee Smith	Cadbury's Rapidly Souring World Global credit woes may keep Cadbury Schweppes from unloading its drinks. Investors, may want to avoid this one.
The Motley Fool August 6, 2007 Rich Smith	Investools Looks Sharp This investor educator/broker is just too big to hype. Investors, take note.
The Motley Fool August 6, 2007 Tom Taulli	EDS in the Slow Lane It looks like competition is dragging growth at the IT giant. And if it is true that Indian rivals are making headway -- which seems reasonable -- then the slowness may continue for some time. Investors, take note.
The Motley Fool August 6, 2007 Timothy M. Otte	Unilever Rolls Through Q2 The Dutch consumer-products company reports solid quarterly results. Investors, take note.
The Motley Fool August 6, 2007 Seth Jayson	Lafarge: The Latest Retreat On the heels of snazzy-looking operating results, the cement giant announced that it would no longer keep its ADRs, because trade in these shares typically amounts to a paltry 1% of its total volume.
The Motley Fool August 6, 2007 Billy Fisher	IDEXX Checks Out in Good Health Earnings continue to surge for this veterinary diagnostics manufacturer. Investors, take note.
<Older 25211-25220 Newer> Return to current articles.